Portfolio

LSP 7

Investments range between EUR 30 million and EUR 60 million

LSP 7 seeks to invest in early-to-late-stage life sciences companies, developing novel and ground-breaking new medicines and technologies that provide solutions to unmet medical needs. LSP 7’s geographical focus is primarily Europe and occasionally the US.

LSP Advisory B.V.
Johannes Vermeerplein 9
1071 DV Amsterdam, the Netherlands

Company Registration Number: 34296447

LSP Advisory B.V. is an alternative investment fund manager authorized and regulated in accordance with laws of the Netherlands.

Fast facts

  • Status
    Aktiv
  • Launch
    2021
  • Storlek
    EUR 1 miljarder

Investment advisory committee

  • Chairperson
    Prof. dr A. Pijpers
  • Egle Therapeutics
  • Evommune
  • HotSpot Therapeutics

Prenumerera

Prenumerera på EQT:s press releaser, regulatoriska press releaser och updates.

Typ av nyheter
Preferred language
EQT logo
En syftesdriven global investeringsorganisation
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180